Reforça't: a Community, Social, and Healthcare Program for Patients with Cardiorespiratory Conditions Upon Hospital Discharge
Launched by CORPORACIÓ DE SALUT DEL MARESME I LA SELVA · Mar 20, 2025
Trial Information
Current as of April 30, 2025
Recruiting
Keywords
ClinConnect Summary
The Reforça't trial is studying a special program designed to help older patients (aged 65 and over) with heart and lung problems after they leave the hospital. The goal is to see if this program can help reduce the number of patients who need to return to the hospital within 30 days and improve their overall health and quality of life. The program offers a mix of medical care, social support, and rehabilitation services tailored to each patient's needs, compared to regular hospital care.
To participate, you need to have been admitted to the hospital for heart or lung issues and live within a certain area. You also need to be willing to join the study by signing a consent form. If you enroll, you will receive a thorough assessment before and after the program, and your health will be monitored for a year to track any hospital readmissions, how well you're doing, and your overall well-being. This program aims to provide better support to help you manage your condition and stay healthy after your hospital stay.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Users admitted to the Polivalent Observation Units, Internal Medicine, or Hospital at home.
- • Individuals aged 65 years or older.
- • Hospital admission due to decompensation of a cardiac, respiratory, or mixed condition.
- • Place of residence within the health coverage area of Sant Jaume de Calella Hospital - Corporació de Salut del Maresme i la Selva.
- • Willingness to participate in the study as gathered by the signing of an informed consent document
- Exclusion Criteria:
- • Users institutionalized in a nursing home
- • Users already enrolled in home care programs
- • Users in the Advanced Chronic Care Model program with a limited life prognosis
- • Users on the waiting list for organ transplantation
- • Users with language barriers
- • Users with a GDS (Global Deterioration Scale) score of 5 or higher
- • Users who have already been included in the Reforça't program
About Corporació De Salut Del Maresme I La Selva
The Corporació de Salut del Maresme i la Selva is a prominent healthcare organization based in Catalonia, Spain, dedicated to providing comprehensive medical services and promoting health research within the region. With a strong commitment to improving patient outcomes, the organization actively sponsors clinical trials that advance medical knowledge and innovation. Their focus on collaboration with academic institutions and industry partners enhances the development of new therapies and treatments, ensuring the highest standards of care and ethical practices in clinical research. Through their efforts, the Corporació de Salut del Maresme i la Selva aims to contribute significantly to the evolution of healthcare and the well-being of the communities they serve.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Calella, Barcelona, Spain
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported